Advertisement
Advertisement

ENTA

ENTA logo

Enanta Pharmaceuticals, Inc

13.64
USD
Sponsored
-0.06
-0.44%
Jul 13, 15:59 UTC -4
Closed
exchange

After-Market

13.63

-0.01
-0.04%

ENTA Earnings Reports

Positive Surprise Ratio

ENTA beat 27 of 41 last estimates.

66%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$18.27M
/
-$0.46
Implied change from Q2 26 (Revenue/ EPS)
+6.50%
/
+2.22%
Implied change from Q3 25 (Revenue/ EPS)
-0.22%
/
-45.88%

Enanta Pharmaceuticals, Inc earnings per share and revenue

On May 11, 2026, ENTA reported earnings of -0.45 USD per share (EPS) for Q2 26, beating the estimate of -0.49 USD, resulting in a 9.60% surprise. Revenue reached 17.16 million, compared to an expected 17.43 million, with a -1.58% difference. The market reacted with a -6.02% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.46 USD, with revenue projected to reach 18.27 million USD, implying an increase of 2.22% EPS, and increase of 6.50% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
FAQ
For Q2 2026, Enanta Pharmaceuticals, Inc reported EPS of -$0.45, beating estimates by 9.6%, and revenue of $17.16M, -1.58% below expectations.
The stock price moved down -6.02%, changed from $15.46 before the earnings release to $14.53 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 6 analysts, Enanta Pharmaceuticals, Inc is expected to report EPS of -$0.46 and revenue of $18.27M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement